Eight Hyped Compounds Failed to Extend Lifespan in a Major Mouse Study
This study suggests that dose and timing matter enormously, and early lifespan results in mice often don't hold up.
The NIA's Interventions Testing Program tested eight compounds across three lab sites in genetically diverse mice. None extended lifespan. That includes astaxanthin, alpha-ketoglutarate, pioglitazone, atorvastatin-telmisartan, and others with prior promising results. Some compounds previously shown to work at different doses or start ages didn't replicate under new conditions. Two drugs actually shortened lifespan in female mice.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchHigher Vitamin C, D, and Carotenoids Linked to Living Longer
U.S. adults with higher blood levels of vitamin C, vitamin D, beta-carotene, and lycopene were less likely to die during the study.
Even Moderate Exercise Can Win Back Years Lost to Multiple Diseases
Having several chronic conditions at once can shave more than 5 years off your life.
For Kidney Patients Over 65, Moving More and Sitting Less Tied to Longer Life
People with kidney disease face a higher risk of dying early.